Astrazeneca Pharmaceuticals 401(k) match, vesting and fees
What Astrazeneca Pharmaceuticals' 401(k) plan says about matching contributions
The maximum amount of the Company match is one dollar for each dollar of the first 6% of eligible compensation that a participant contributes to the Plan.
Quoted directly from the filing. Plan terms may have changed; check your current Summary Plan Description.
Plan features
Indented passages are quoted word for word from the audit report; plan terms may have changed since, so check your current Summary Plan Description.
| Employer match | Quoted from the filing above | 2024 audit report, p. 146 ↗ |
| Match vesting | As it relates to AZ Retirement Company Contributions for eligible participants, a participant who is credited with at least one hour of service on or after January 1, 2007 becomes fully vested in his or her AZ Retirement Company Contributions after the completion of three years of service. All other participants are immediately vested in their contributions and all Company matching contributions, plus actual earnings thereon. If a participant is involuntarily terminated as a result of a Company restructuring, layoff or job elimination, their account will become fully (100%) vested if they would have otherwise become fully vested under the terms of the Plan no later than the six month anniversary of the date of their involuntary termination. | 2024 audit report, p. 147 ↗ |
| Roth contributions | Participants can make before-tax or after-tax (including ROTH) contributions of up to 50% of annual eligible compensation. The maximum amount of the Company match is one dollar for each dollar of the first 6% of eligible compensation that a participant contributes to the Plan. Participants age 50 and over are eligible to contribute additional before-tax and ROTH contributions (“catch-up contributions”) above the annual Internal Revenue Service ("IRS") limitations up to $7,500 in 2024. | 2024 audit report, p. 146 ↗ |
| Loans | The Plan allows plan loans pursuant to Section 408(b)(1) of ERISA and the regulations thereunder. The maximum loan amount is the lesser of 50% of a participant’s account balance or $50,000, excluding any amounts in the AZ Retirement Company Contributions and reduced by the participant’s highest outstanding plan loan balance over the previous 12 months. The minimum loan amount is $1,000 and the maximum is two loans outstanding at any time for any eligible borrower. | 2024 audit report, p. 147 ↗ |
| Recordkeeper | Fid Inv Inst Ops Co | 2025 Schedule C ↗ |
| Independent auditor | Pricewaterhousecoopers LLP (unmodified opinion) | 2025 Schedule H ↗ |
| Plan type and status | 401(k) · Active | 2025 Form 5500 ↗ |
Match, vesting and other plan features are from the plan year 2024 filing's audit report (the latest one extracted so far). Rows cited to the Form 5500 and its schedules are from the plan year 2025 filing.
How the plan compares
Plan year 2025 medians for 65 defined-contribution plans in manufacturing with 10,000 to 49,999 participants.
| Astrazeneca Pharmaceuticals: employer contribution per participant | $8,812 | |
| Peer median | $3,789 |
| Astrazeneca Pharmaceuticals: average balance | $363,949 | |
| Peer median | $192,757 |
| Astrazeneca Pharmaceuticals: admin expenses ÷ assets | <0.01% | |
| Peer median | 0.04% |
Admin expenses are the plan's reported administrative expenses divided by its assets; they do not include fund expense ratios.
Plan history
Plan assets went from $7.2B at the end of plan year 2021 to $9.6B at the end of plan year 2025.
| Plan year | Participants | Assets | Employer contributions | Per participant | Admin expense ratio | Match formula | Filing |
|---|---|---|---|---|---|---|---|
| 2025 | 27,192 | $9.6B | $233M | $8,812 | <0.01% | Not published | Form 5500 ↗ |
| 2024 | 27,394 | $8.6B | $233M | $8,737 | <0.01% | Quoted in the audit report, p. 146 ↗ | Form 5500 ↗ |
| 2023 | 26,829 | $7.6B | $194M | $7,427 | <0.01% | Not published | Form 5500 ↗ |
| 2022 | 22,375 | $6.1B | $180M | $8,237 | 0.01% | Not published | Form 5500 ↗ |
| 2021 | 21,746 | $7.2B | $177M | $8,304 | 0.01% | Not published | Form 5500 ↗ |
Other Astrazeneca Pharmaceuticals plans (2)
Each plan files its own Form 5500. Figures are from each plan's latest filing.
Astrazeneca Savings and Security Plan for Puerto Rico Employees
Plan features
Match, vesting and enrollment details have not been published from this plan's audit report yet. The figures below come from the structured filing.
| Plan type and status | 401(k) · Active | Form 5500 ↗ |
Astrazeneca Defined Benefit Pension Plan
Plan features
Match, vesting and enrollment details have not been published from this plan's audit report yet. The figures below come from the structured filing.
| Independent auditor | Pricewaterhousecoopers LLP (unmodified opinion, limited scope) | Schedule H ↗ |
| Plan type and status | Pension (defined benefit) · Terminated (final filing) | Form 5500 ↗ |
Common questions
Does Astrazeneca Pharmaceuticals match 401(k) contributions?
The audit report attached to the Astrazeneca Savings and Security Plan's plan year 2024 Form 5500, page 146 says: “The maximum amount of the Company match is one dollar for each dollar of the first 6% of eligible compensation that a participant contributes to the Plan.” Plan terms may have changed; check your current Summary Plan Description.
When is the Astrazeneca Pharmaceuticals 401(k) match vested?
The audit report attached to the plan year 2024 Form 5500, page 147 says: “As it relates to AZ Retirement Company Contributions for eligible participants, a participant who is credited with at least one hour of service on or after January 1, 2007 becomes fully vested in his or her AZ Retirement Company Contributions after the completion of three years of service. All other participants are immediately vested in their contributions and all Company matching contributions, plus actual earnings thereon. If a participant is involuntarily terminated as a result of a Company restructuring, layoff or job elimination, their account will become fully (100%) vested if they would have otherwise become fully vested under the terms of the Plan no later than the six month anniversary of the date of their involuntary termination.”
Who manages the Astrazeneca Pharmaceuticals 401(k)?
The recordkeeper listed on Schedule C of the plan year 2025 filing is Fid Inv Inst Ops Co. The plan administrator is Astrazeneca Administration Committee.
I left Astrazeneca Pharmaceuticals. How do I find my old 401(k)?
Your account stays in the plan until you move it. Contact the plan administrator (Astrazeneca Administration Committee, (302) 886-3000) or the recordkeeper, Fid Inv Inst Ops Co. The Astrazeneca Pharmaceuticals old 401(k) page lists the contacts from every plan filing. Find an old Astrazeneca Pharmaceuticals 401(k)
Data from the public Form 5500 annual reports Astrazeneca Pharmaceuticals filed with the U.S. Department of Labor (plan years 2021 and 2022 and 2023 and 2024 and 2025) and, where noted, the attached independent auditor's report. Plan terms may have changed since the filing; check your current Summary Plan Description. PlanFacts is not affiliated with Astrazeneca Pharmaceuticals. Not financial advice. Report a correction · Methodology